...
机译:MACC1对人恶性神经胶质瘤进展和患者预后不良的影响
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Institute of Pathology, Department of Neuropathology, University of Wurzburg, Wurzburg, Germany;
Experimental and Clinical Research Center, Charite University Medicine Berlin and the Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany;
Department of Anatomy and Cell Biology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany;
Max-Delbruck-Center for Molecular Medicine, Berlin, Germany;
Max-Delbruck-Center for Molecular Medicine, Berlin, Germany;
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Max-Delbruck-Center for Molecular Medicine, Berlin, Germany;
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Department of Neurosurgery, Tumorbiology Laboratory, University of Wurzburg, Wurzburg, Germany;
Experimental and Clinical Research Center, Charite University Medicine Berlin and the Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Strasse 10,13125 Berlin, Germany;
astrocytoma WHO grade Ⅱ; glioblastoma multiforme; MACC1; prognostication; progression;
机译:神经降压素通过NTSR1促进恶性神经胶质瘤的进展并影响神经胶质瘤患者的预后
机译:伴随的microRNA-31下调和放射蛋白上调预示神经胶质瘤患者的晚期肿瘤进展和不良预后
机译:LKB1的下调促进肿瘤进展,并预测胶质瘤患者的不利预后
机译:MicroRNA分析在Gliomas的恶性进展中
机译:CDKN2A基因在人类恶性神经胶质瘤进展中的生物学作用。
机译:MACC1对人恶性神经胶质瘤进展和患者预后不良的影响
机译:神经降压素通过NTSR1促进恶性神经胶质瘤的进展并影响神经胶质瘤患者的预后